These are the stocks posting the largest moves before the bell.Market Insiderread more
But the bank's net interest margin, a key metric of bank profitability, falls short of expectations.Financeread more
If the S&P 500 climbs another 4%, it will have doubled the peak reached in the previous bull market, Michael Santoli notes.Trading Nationread more
The EU opened a formal antitrust investigation into Amazon on Wednesday centered on how the e-commerce giant uses merchants' data.Technologyread more
Ascending triangle patterns have been appearing across the stock market, and they tend to be precursors to higher prices, says Miller Tabak's Matt Maley.Trading Nationread more
Turo is a peer-to-peer car-sharing firm that is often referred to as the Airbnb for cars.Technologyread more
Mortgage interest rates surged last week to their highest level in a month, and consequently homebuyers turned on their heels.Real Estateread more
U.S. officials see the deal as a threat to NATO, for which Turkey provides the second-largest military.World Politicsread more
Google's services have been blocked in China for several years, but the company still has a business there, as the tech giant seeks to sell products to Chinese firms in...Technologyread more
"The charts, as interpreted by Carley Garner, suggest that the upside in the stock market has gotten more limited," Jim Cramer says.Mad Money with Jim Cramerread more
China may have signaled it's going more hard-line on trade, but it could be a good thing, former U.S. negotiator Clete Willems told CNBC.World Economyread more
St. Jude agreed in April to be purchased by Abbott Laboratories.
"If the deal were to break, I think that we could be $55 or lower," Block said in an interview with "Closing Bell. "
Muddy Waters published a report announcing its short position in St. Jude on Thursday after receiving a report by cybersecurity firm MedSec that claimed St. Jude's cardiac devices are vulnerable to cyberattacks.
MedSec CEO Justine Bone told "Closing Bell" on Friday that she made the unconventional decision to go to Muddy Waters instead of St. Jude with the findings because St. Jude had a history of not responding to security concerns.
"We have not seen St. Jude raise the bar, unlike some of their competitors who have put some basic protections in place," she alleged.
Block also defended his decision to not approach St. Jude with the findings and instead potentially profit by shorting the stock.
"This isn't an oversight or small little hole that you have to look very hard to find. These are gaping holes," he said. "This is a company that will ultimately be held to be grossly negligent."
On Friday, St. Jude disputed the allegations made by Muddy Waters Capital and MedSec.
"We have examined the allegations made by Muddy Waters Capital and MedSec ... and we conclude that the report is false and misleading," it said in a detailed statement.
It called the test methodology used by MedSec "flawed" and said its software has been evaluated by several independent organizations.
"St. Jude Medical will remain ever vigilant and dedicated to patient safety," the statement said.
Shares of St. Jude were temporarily halted Friday afternoon before resuming trading and closing up 19 cents at $78.01.
— CNBC's Christine Wang contributed to this report.